Yescarta
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2355 Utah Ave, El Segundo, California, 9...Website
www.yescarta.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Yescarta
Yescarta is a pharmaceutical company that specializes in CAR T-cell therapy for adults with certain types of non-Hodgkin lymphoma. The company develops innovative immunotherapy treatments that harness the body's immune system to fight cancer. Yescarta's flagship product was the first CAR T-cell therapy approved for specific lymphoma indications, representing a significant advancement in cancer treatment options. The company provides educational resources and support for patients considering this therapeutic approach.Explore more
Popular SearchesYescartaKite Pharma IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Yescarta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Yescarta has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Yescarta is spiking on competitors!
Yescarta, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Yescarta had a recent Job posting/layoffs
Product Launch: Get notified when Yescarta launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Yescarta recently announced quarterly report
Funding: Get notified immidiatlly once Yescarta has new funding data
Congratulate Masked Content for being promoted to Masked Content at Yescarta
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Yescarta
Compare insights from companies similar to Yescarta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Yescarta
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Yescarta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Yescarta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Yescarta.
Yescarta Tech Stack
A closer look at the technologies used by Yescarta
Yescarta News & Media
Kite's YESCARTA® (Axicabtagene Ciloleucel) Reimbursed in Alberta for the Treatment of Certain ...
/CNW/ - Gilead Sciences Canada, Inc. (Gilead Canada) announced today that YESCARTA® (axicabtagene ciloleucel) is now available in Alberta as a treatment for...
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Yescarta
Sign Up For FreeTo access detailed company insights
Yescarta is a pharmaceutical company that specializes in CAR T-cell therapy for adults with certain types of non-Hodgkin lymphoma. The company develops innovative immunotherapy treatments that harness the body's immune system to fight cancer. Yescarta's flagship product was the first CAR T-cell therapy approved for specific lymphoma indications, re... Read More
